BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31450167)

  • 21. Synthesis, anticancer and antioxidant properties of new indole and pyranoindole derivatives.
    Iacopetta D; Catalano A; Ceramella J; Barbarossa A; Carocci A; Fazio A; La Torre C; Caruso A; Ponassi M; Rosano C; Franchini C; Sinicropi MS
    Bioorg Chem; 2020 Dec; 105():104440. PubMed ID: 33217633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of substituted biphenyl methylene indolinones as apoptosis inducers and tubulin polymerization inhibitors.
    Donthiboina K; Anchi P; Sri Ramya PV; Karri S; Srinivasulu G; Godugu C; Shankaraiah N; Kamal A
    Bioorg Chem; 2019 May; 86():210-223. PubMed ID: 30716619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
    Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
    Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of indole-based [1,2,4]triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors.
    Wu CJ; Wu JQ; Hu Y; Pu S; Lin Y; Zeng Z; Hu J; Chen WH
    Eur J Med Chem; 2021 Nov; 223():113629. PubMed ID: 34175541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors.
    Kode J; Kovvuri J; Nagaraju B; Jadhav S; Barkume M; Sen S; Kasinathan NK; Chaudhari P; Mohanty BS; Gour J; Sigalapalli DK; Ganesh Kumar C; Pradhan T; Banerjee M; Kamal A
    Bioorg Chem; 2020 Dec; 105():104447. PubMed ID: 33207276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
    Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
    Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
    Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
    Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study.
    Saruengkhanphasit R; Butkinaree C; Ornnork N; Lirdprapamongkol K; Niwetmarin W; Svasti J; Ruchirawat S; Eurtivong C
    Bioorg Chem; 2021 May; 110():104795. PubMed ID: 33730670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity.
    Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A
    Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of an indole-substituted furanone with tubulin polymerization inhibition activity.
    Mowery P; Filkorn MM; Hurysz B; Kwansare DO; Lafferty MM; McFadden MA; Neerukonda ND; Patel RR; Pierce K; Sockett KA; Truax NJ; Webster NR; Pelkey ET
    Bioorg Med Chem Lett; 2021 Jun; 41():127991. PubMed ID: 33775833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment.
    Abdel-Motaal M; Aldakhili DA; Abo Elmaaty A; Sharaky M; Mourad MAE; Alzahrani AYA; Mohamed NA; Al-Karmalawy AA
    Drug Dev Res; 2024 Jun; 85(4):e22197. PubMed ID: 38751223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain.
    Li W; Yin Y; Shuai W; Xu F; Yao H; Liu J; Cheng K; Xu J; Zhu Z; Xu S
    Bioorg Chem; 2019 Mar; 83():380-390. PubMed ID: 30408650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
    Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties as Tubulin Polymerization Inhibitors.
    Wang G; Peng Z; Li Y
    Chem Pharm Bull (Tokyo); 2019 Jul; 67(7):725-728. PubMed ID: 30982797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-Arylsulfonylsubstituted-1H indole derivatives as small molecule dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and tubulin.
    Zhou Q; Zhu J; Chen J; Ji P; Qiao C
    Bioorg Med Chem; 2018 Jan; 26(1):96-106. PubMed ID: 29174507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
    Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
    Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization.
    Zhang R; Mo H; Ma YY; Zhao DG; Zhang K; Zhang T; Chen X; Zheng X
    Bioorg Med Chem Lett; 2021 May; 40():127968. PubMed ID: 33753264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.